Roberts Glore & Co »

United Therapeutics Corporation shares owned by Roberts Glore & Co

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Roberts Glore & Co from 13F filings

Historical chart of Roberts Glore & Co investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Roberts Glore & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Roberts Glore & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $244k 451 541.83

More positions owned by Roberts Glore & Co

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Total Stk Mkt (VTI)
Abbvie (ABBV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Amazon (AMZN)
Cisco Systems (CSCO)
NVIDIA Corporation (NVDA)
Sprott Asset Management Physical Gold An (CEF)
Abbott Laboratories (ABT)

View all positions for Roberts Glore & Co

Top funds holding United Therapeutics Corporation

BlackRock
venBio Select Advisor
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Wellington Management Company
Geode Capital Management
Henderson Group
Jupiter Topco
Caption Management
Citadel Advisors
Susquehanna International
Norges Bank Investment Management
Assetmark

View all funds holding United Therapeutics Corporation